Literature DB >> 12773624

Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta.

Yi Lisa Lyu1, James C Wang.   

Abstract

We have examined corticogenesis in mouse embryos lacking DNA topoisomerase IIbeta (IIbeta) in the brain or in all tissues. The absence of IIbeta, a type II DNA topoisomerase normally expressed in postmitotic cells in the developing cortex, severely affects cerebral stratification: no subplate is discernible, and neurons born at later stages of corticogenesis fail to migrate to the superficial layers. This abnormal pattern of neuron positioning in the cerebral cortex is reminiscent of that observed in mouse mutants defective in the reelin-signaling pathway. Significantly, the level of reelin in the neocortex is much reduced when IIbeta is absent. These results implicate a role of IIbeta in brain development. The enzyme may be required in implementing particular genetic programs in postmitotic cells, such as reelin expression in Cajal-Retzius cells, perhaps through its action on nucleoprotein structure of particular chromosomal regions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773624      PMCID: PMC165840          DOI: 10.1073/pnas.1232376100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  DNA topoisomerase IIbeta and neural development.

Authors:  X Yang; W Li; E D Prescott; S J Burden; J C Wang
Journal:  Science       Date:  2000-01-07       Impact factor: 47.728

2.  Recruitment of cdc2 kinase by DNA topoisomerase II is coupled to chromatin remodeling.

Authors:  A E Escargueil; S Y Plisov; A Skladanowski; A Borgne; L Meijer; G J Gorbsky; A K Larsen
Journal:  FASEB J       Date:  2001-08-17       Impact factor: 5.191

Review 3.  Eukaryotic DNA topoisomerase II beta.

Authors:  C A Austin; K L Marsh
Journal:  Bioessays       Date:  1998-03       Impact factor: 4.345

Review 4.  Untangling the role of DNA topoisomerase II in mitotic chromosome structure and function.

Authors:  P E Warburton; W C Earnshaw
Journal:  Bioessays       Date:  1997-02       Impact factor: 4.345

5.  Topoisomerase-II-mediated DNA cleavage within the human ribosomal genes.

Authors:  M Govoni; S Neri; T Labella; J E Sylvester; F Novello; A Pession
Journal:  Biochem Biophys Res Commun       Date:  1995-08-04       Impact factor: 3.575

6.  DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe.

Authors:  T Uemura; H Ohkura; Y Adachi; K Morino; K Shiozaki; M Yanagida
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

7.  DNA topoisomerase IIalpha interacts with CAD nuclease and is involved in chromatin condensation during apoptotic execution.

Authors:  F Durrieu; K Samejima; J M Fortune; S Kandels-Lewis; N Osheroff; W C Earnshaw
Journal:  Curr Biol       Date:  2000 Jul 27-Aug 10       Impact factor: 10.834

8.  Modulation of human DNA topoisomerase IIalpha function by interaction with 14-3-3epsilon.

Authors:  E U Kurz; K B Leader; D J Kroll; M Clark; F Gieseler
Journal:  J Biol Chem       Date:  2000-05-05       Impact factor: 5.157

9.  Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells.

Authors:  S O'Gorman; N A Dagenais; M Qian; Y Marchuk
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

10.  Chromatid segregation at anaphase requires the barren product, a novel chromosome-associated protein that interacts with Topoisomerase II.

Authors:  M A Bhat; A V Philp; D M Glover; H J Bellen
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

View more
  57 in total

1.  Regulation of DNA Topoisomerase IIbeta through RNA-dependent association with heterogeneous nuclear ribonucleoprotein U (hnRNP U).

Authors:  Shinji Kawano; Mary Miyaji; Shoko Ichiyasu; Kimiko M Tsutsui; Ken Tsutsui
Journal:  J Biol Chem       Date:  2010-06-16       Impact factor: 5.157

Review 2.  The function of DNA topoisomerase IIβ in neuronal development.

Authors:  Xin Heng; Wei-Dong Le
Journal:  Neurosci Bull       Date:  2010-10       Impact factor: 5.203

3.  Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNA.

Authors:  Javier Salceda; Xavier Fernández; Joaquim Roca
Journal:  EMBO J       Date:  2006-05-18       Impact factor: 11.598

4.  Tyrosine 656 in topoisomerase IIβ is important for the catalytic activity of the enzyme: Identification based on artifactual +80-Da modification at this site.

Authors:  Adrian G Grozav; Belinda B Willard; Toshiyuki Kozuki; Kenichi Chikamori; Marius A Micluta; Andrei-Jose Petrescu; Michael Kinter; Ram Ganapathi; Mahrukh K Ganapathi
Journal:  Proteomics       Date:  2011-01-31       Impact factor: 3.984

Review 5.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

Review 6.  Topoisomerases and the regulation of neural function.

Authors:  Peter J McKinnon
Journal:  Nat Rev Neurosci       Date:  2016-09-15       Impact factor: 34.870

7.  Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.

Authors:  Anna M Azarova; Yi Lisa Lyu; Chao-Po Lin; Yuan-Chin Tsai; Johnson Yiu-Nam Lau; James C Wang; Leroy F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

8.  p53 Deficiency rescues neuronal apoptosis but not differentiation in DNA polymerase beta-deficient mice.

Authors:  Noriyuki Sugo; Naoko Niimi; Yasuaki Aratani; Keiko Takiguchi-Hayashi; Hideki Koyama
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

9.  The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage.

Authors:  Timothy J Wendorff; Bryan H Schmidt; Pauline Heslop; Caroline A Austin; James M Berger
Journal:  J Mol Biol       Date:  2012-07-25       Impact factor: 5.469

Review 10.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.